Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transgenic hookworm secretes anti-tetrodotoxin human single chain antibody.

Nature communications·2026
Same author

Oocyte-inspired universal whole-cell vaccines against tumor heterogeneity.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Biosilicification across Biological Hierarchies.

ACS nano·2026
Same author

33 Unresolved Questions in Nanoscience and Nanotechnology.

ACS nano·2025
Same author

Local administration of lipid-silica nanohybrid-carried forskolin modulates thermogenesis in human adipocytes and impedes weight gain in mice.

Advanced functional materials·2025
Same author

Unlocking tumor barrier: annexin A2-mediated transcytosis boosts drug delivery in pancreatic and breast tumors.

Nature communications·2025

Related Experiment Video

Updated: May 14, 2026

Designing Porous Silicon Films as Carriers of Nerve Growth Factor
10:12

Designing Porous Silicon Films as Carriers of Nerve Growth Factor

Published on: January 25, 2019

Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.

Derrick Tarn1, Carlee E Ashley, Min Xue

  • 1Department of Chemical and Nuclear Engineering, the University of New Mexico, Albuquerque, NM 87131, USA.

Accounts of Chemical Research
|February 8, 2013
PubMed
Summary

Ordered mesoporous silica nanoparticles (MSNPs) are versatile nanocarriers for drug delivery, offering high cargo capacity and controlled release. Their biocompatibility and tunable properties enable advanced applications in imaging and targeted therapies.

More Related Videos

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
08:53

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Published on: April 16, 2019

Related Experiment Videos

Last Updated: May 14, 2026

Designing Porous Silicon Films as Carriers of Nerve Growth Factor
10:12

Designing Porous Silicon Films as Carriers of Nerve Growth Factor

Published on: January 25, 2019

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
08:31

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
08:53

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Published on: April 16, 2019

Area of Science:

  • Materials Science and Nanotechnology
  • Biomedical Engineering
  • Drug Delivery Systems

Background:

  • Ordered mesoporous silica nanoparticles (MSNPs) have emerged as promising nanocarriers due to their unique structural properties.
  • Their high surface area, tunable pore size, and surface chemistry facilitate efficient loading and delivery of diverse cargos.
  • Previous research has focused on utilizing MSNPs for drug delivery, but further development is needed for multi-functional applications.

Purpose of the Study:

  • To develop biocompatible MSNPs engineered for multiple functionalities.
  • To enhance MSNPs for imaging, dispersibility, target binding, high cargo loading, and controlled release.
  • To explore MSNPs as advanced nanocarriers for therapeutic applications.

Main Methods:

  • MSNPs were synthesized using colloidal chemistry and evaporation-induced self-assembly.
  • Functionalization strategies included conjugation of imaging agents (dyes, magnetic nanoparticles), surface coatings (polymers, lipid bilayers), and ligand attachment.
  • Cargo loading was optimized by exploiting noncovalent interactions and high surface area; controlled release was achieved using molecular machines and responsive coatings.

Main Results:

  • Engineered MSNPs demonstrated high visibility in multiple imaging modalities (optical, MRI).
  • Improved dispersibility and stability in saline solutions were achieved through surface modifications.
  • Enhanced targeting specificity to cancer cells and high loading capacities for diverse cargos, including hydrophobic drugs, were observed.
  • Incorporation of molecular machines and lipid bilayers enabled triggered cargo release and controlled cellular interactions.

Conclusions:

  • MSNPs can be engineered as multi-functional, biocompatible nanocarriers for advanced drug delivery and imaging.
  • Surface modification and incorporation of responsive elements significantly enhance their therapeutic potential.
  • Future MSNPs with integrated molecular machines and lipid bilayers promise sophisticated controlled cellular interactions and targeted therapies.